An D. Nguyen, M.D.
CAREER MISSION STATEMENT
Focus on providing excellent quality and compassionate care to all cancer patients and offer them advanced and target therapies to improve and enhance the quality of the life of every patient.
EDUCATION
1994 – 1998 M.D., Albany Medical College, Albany, NY
1989 – 1994 B.S., in Biology
University of California, Irvine, Irvine, CA
– 1994 B.A., in Comparative Cultures
University of California, Irvine, Irvine, CA
POST GRADUATE TRAINING
2001 – 2004 Hematology/Oncology Fellowship
Cedars-Sinai/Olive View Medical Centers, Los Angeles, CA
1998 – 2001 Internal Medicine Residency
Albany Medical Center, Albany, NY
PROFESSIONAL EXPERIENCE
– Present Compassionate Cancer Care Medical Group, Inc.
11180 Warner Avenue, Suite 365, Fountain Valley, CA 92708
260 E. Ontario Avenue, Suite 101, Corona, CA 92879
4500 Brockton Avenue, Suite 107, Riverside, CA 92501
PROFESSIONAL ASSOCIATIONS
2001 - Present American Society of Clinical Oncology
2001 - Present American Society of Hematology
1998 - Present American College of Physicians
PROFESSIONAL ASSOCIATIONS, continued
1996 - 1997 American Medical Student Association
- National Chapter
- Region II representative and AIDS Action Council Liaison
1995-1996 American Medical Student Association
- Albany Medical College chapter
- President and member
1994-Present American Medical Association
1992-1994 Alpha Epsilon Delta, University of California, Irvine
PROFESSIONAL ACTIVITIES
1998 – 2001 Albany Medical Review
Editor and contributing author
Owen Clinic, University of California, San Diego Medical Center
HIV medicine preceptorship
1994 – 1998 AIDS Education Program, Albany Medical College
Program Coordinator
1994 – 1995 AIDS Treatment Center, Albany Medical Center
Preceptorship
1992 – 1993 AIDS Services Foundation of Orange County, Irvine, California
Emotional support volunteer
– 1993 Community Clinic of Orange County, Santa Ana, California
Team leader and Vietnamese translator for refugees
1990 – 1994 Flying Samaritans, University of California, Irvine
President, Vice-President, and Treasurer of a non-profit organization providing dental and medical services for the community of El Testerazo, Mexico
LICENSURE
2001-Present California License #A78574
BOARD CERTIFICATION
2007 Board Certified, American Board of Oncology
2004 Board Certified, American Board of Internal Medicine
Board Eligible, American Board of Hematology
BIOGRAPHICAL DATA
Date of Birth: November 20, 1971
Place of Birth: Saigon, Vietnam
Citizenship: United States
CLINICAL RESEARCH ACTIVITY
BREAST CANCER
A Randomized Controlled Study of Docetaxel Monotherapy or DOXIL/ CAELYX and Docetaxel for the Treatment of Advanced Breast Cancer.
Sub-Investigator
A Phase 3 Randomized, Placebo-Controlled, Double-Blind Study of Oral CCI-779, Administered in Combination With Letrozole vs. Letrozole Alone as First Line Hormonal Therapy in Post-Menopausal A Women with Locally Advanced or Metastatic Breast Cancer
Sub-Investigator
A Randomized, Double-Blind, Placebo-Controlled, 2-Arm, Phase III Study of Oral GW572016 In Combination with PACLITAXEL in Subjects Previously Untreated For Advanced (Stage IIIB) or Metastatic Breast (Stage IV) Cancer
Sub-Investigator
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase III Study Comparing GW572016 and Letrozole vs. Letrozole in Subjects with Estrogen /Progesterone Receptor-Positive Advanced (Stage IIIB) or Metastatic (Stage IV) Breast Cancer
Sub-Investigator
A Randomized, Double-Blind, Study To Compare Efficacy & Tolerability Of Fulvestrant FASLODEX™ vs. Exemestane AROMASIN™ in Post-Menopausal Women With Hormone Receptor Positive Advanced Breast Cancer with Disease Progression After Prior Non-Steroidal AROMATASE Inhibitor (AI) Therapy.
Sub-Investigator
A Randomized, Open-Label, Phase III Study of RPR109881 IV Every 3 Weeks vs. Capcitabine (XELODA®) Tablets Twice Daily For 2 Weeks in 3-Week Cycles in patients with Metastatic breast cancer progressing after Taxanes and Anthracycline therapy.
Sub-Investigator
COLORECTAL CANCER
A Phase III Randomized, Open-Label, Multicenter Study of Irinotecan and Cetuximab vs. Irinotecan as a Second Line Treatment in Patients with Metastatic EGFR-Positive Colorectal Cancer.
Sub-Investigator
CLINICAL RESEARCH ACTIVITY (continued)
COLORECTAL CANCER, continued
A Phase III Randomized, Open-Label, Multicenter Study Of Irinotecan & Cetuximab vs. Irinotecan as Second-Line Treatment in Patients with Metastatic, EGFR-Positive Colorectal Carcinoma.
Sub-Investigator
A Phase III Randomized, Multicenter Study Of Cetuximab, Oxaliplatin, 5-FU, & Leucovorin vs. Oxaliplatin, 5-FU, & Leucovorin in Patients With Previously Treated Metastatic EGFR-Positive Colorectal Carcinoma.
Sub-Investigator
A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of Oxaliplatin/5-FU / Leucovorin with PTK787/ZK222584 or Placebo in Patients with Previously Treated Metastatic Adenocarcinoma of the Colon or Rectum.
Sub-Investigator
A Randomized, Phase III Trial of Irinotecan and Avastin in Combination with Three Different Methods in Administration of Fluoropyrimidine: Infusional 5-FU (FOLFIRI), Modified-Bolus 5-FU (Day 1&8), with Celecoxib vs. Placebo as First-Line treatment for Patients with Metastatic Colorectal Cancer.
A 2X2 Factorial Randomized Study of XELOX With/Without IV Avastin (Q3W) vs. FOLFOX4 (Q2W) as First-Line treatment for patients with Metastatic Colorectal Cancer.
LUNG CANCER
A Multi-center Randomized Phase III Study of Taxotere and Carboplatin vs Taxotere and Gemcitabine in Patients with Advanced Non Small Lung Cancer.
Sub-Investigator
A Phase II Trial of Twice Daily Oral Topotecan as a Radiation Sensitizer with Twice Daily Radiotherapy for Newly Diagnosed Small Cell Lung Cancer
Phase 3 Trial of Gemcitabine Plus Cisplatin vs Cisplatin Alone in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer. Sub-Investigator
CLINICAL RESEARCH ACTIVITY (continued)
PROSTATE CANCER
Phase III Randomized, Open-Label Study of CG1940 and CG8711 vs. Docetaxel & Estrumustine in Patients with Metastatic Hormone-Refractory Prostate Cancer who are Chemotherapy Naïve
Sub-Investigator
SUPPORTIVE THERAPY
A Randomized, Open-Label, Study of Epoetin Alfa (Procrit®) vs. Darbepoetin Alfa (Aranesp™) to Evaluate Hematologic Response Rate in Anemic Cancer Patients Receiving Chemotherapy.
Sub-Investigator
A Randomized, Open Label, Multicenter Study of Primary Prophylaxis with NEULASTA™ (Pegfilgrastim) vs. Secondary Prophylaxis as an Adjunct to Chemotherapy in Elderly Subjects (≤65y.o.) with Cancer.
Sub-Investigator
A Double-Blind, Randomized, Placebo-Controlled Parallel –Group, Efficacy Study of Oral Dronabinol Alone and in Combination with Ondansetron vs. Ondansetron Alone in Subjects with Delayed Chemotherapy-Induced Nausea and Vomiting.
Sub-Investigator
A Double-Blind, Placebo-Controlled, Study and Open-Label, Long Term Study of an Oravescent™ Fentanyl Citrate for Treatment of Break-Through Pain in Opioid-Tolerant Cancer Patients.
Sub-Investigator
2003 Prevention of delayed nausea and vomiting with the addition of a neurokinin-1 antagonist to Ondansetron and dexamethasone with high-dose chemotherapy followed by autologous stem cell transplant
- Cedars-Sinai Medical Center, Department of Hematology/Oncology, Division of Blood & Bone Marrow Transplantation
2002 Contribution of clarithromycin when combined with thalidomide and dexamethasone for the treatment of multiple Myeloma
- Cedars-Sinai Medical Center, Department of Hematology/Oncology, Division of Multiple Myeloma
CLINICAL RESEARCH ACTIVIT
Y (continued)
1999 Whole body FDG-PET scans in the management of non-Hodgkin’s lymphoma
- Cedars-Sinai Medical Center, Department of Nuclear Medicine
1997 Progressive multifocal leukoencephalopathy in HIV individuals despite effective triple therapy
- Abstract accepted at the 5th Conference on Retroviruses and Opportunistic Infections
- Albany Medical Center, Department of HIV Medicine,
1997 Management of low grade abnormal pap smears
- Poster presented at the Society of Teachers of Family Medicine Conference
- Family Health Center, Saint Clare’s Hospital, Department of Family Practice
1995 Alternative therapies in the treatment of HIV+ individuals
- University of California, San Diego Medical Center, Department of Medicine
1992 – 1993 Analysis of fetal alcohol syndrome on cognitive learning
- University of California, Irvine, Department of Developmental Psychobiology